Skip to content

Author

Weiming Liang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Meta-analysis Open access Sep 2026

Comparison of bivalirudin versus heparin in percutaneous coronary intervention for patients with acute coronary syndrome

Bivalirudin may offer advantages over heparin in reducing in-hospital and 30-day mortality and major bleeding in patients with ACS undergoing PCI, with no significant differences in ischemic outcomes such as MACEs, MI, ST, or stroke.

Chen Yang, Zhen-De Ning, Wei-Ming Liang et al. · 0 citations
Open access Jul 2026

Efficacy and safety of PD-1/PD-L1 inhibitors versus chemotherapy or cetuximab in the treatment of platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma: a meta-analysis

Introduction This meta-analysis was designed to compare the efficacy and safety of PD-1/PD-L1 inhibitors versus chemotherapy or cetuximab in the treatment of platinum-refractory recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). Materials and Methods Four databases (PubMed, Embase, Web of Science,...

Zhong-Ji Chen, Zhong Zhong, Weiming Liang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.